In this article, we are going to take a look at where Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) stands against other Friday’s best-performing stocks. Recursion Pharmaceuticals grew its share ...

Phathom Pharmaceuticals, Inc. announced that the FDA has approved its Citizen Petition, recognizing 10 years of New Chemical Entity exclusivity for its medication VOQUEZNA® (vonoprazan ...

Telix Pharmaceuticals Ltd. + Watchlist Alert TLPPF US Closed Last Updated: Jun 6, 2025 3:50 p.m. EDT Delayed quote $ 16.60-0.56-3.26% Previous Close $17.16 Toggle Chart Options Advanced Charting ...

In a report released on June 4, Dennis Ding from Jefferies maintained a Buy rating on Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) with a price target of $80.00. The analyst based the rating on the ...

Kiniksa Pharmaceuticals International PLC + Watchlist Alert KNSA US Open Last Updated: Jun 5, 2025 2:09 p.m. EDT Real time quote $ 29.39 0.51 1.77% Previous Close $28.88 Toggle Chart Options ...

The Council is ready to begin negotiations with the European Parliament, having agreed its position on new rules that aim to make the EU’s pharmaceutical sector fairer and more competitive. The ...

Bishop may have only spent one year in the Mountaineer program, but he knows exactly how much the Backyard Brawl means to the folks in the Mountain State and has a deep disdain for the school up ...

Orlando has brought back a version of its classic logo and showed off 3 new uniform looks for next season. Official release Franz Wagner, Jalen Suggs and Paolo Banchero model some of the Magic’s ...

That’s a major concern as US President Donald Trump threatens to impose tariffs on pharmaceutical imports, throwing a spotlight on America’s dependence on critical drug supplies from abroad.

First-line maintenance combination therapy reduced the risk of disease progression or death by 46%, with a median overall survival of 13.2 months vs 10.6 months for atezolizumab alone from the ...

DUBLIN, June 2, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term data, including the first report of median overall survival (OS) from the Phase 2 trial ...